GIUNTA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 11.977
AS - Asia 1.723
EU - Europa 1.709
Continente sconosciuto - Info sul continente non disponibili 304
SA - Sud America 222
AF - Africa 79
OC - Oceania 37
Totale 16.051
Nazione #
US - Stati Uniti d'America 11.869
SG - Singapore 572
CN - Cina 348
IT - Italia 293
BR - Brasile 183
RU - Federazione Russa 178
DE - Germania 165
FR - Francia 156
HK - Hong Kong 144
GB - Regno Unito 140
SE - Svezia 137
VN - Vietnam 127
UA - Ucraina 125
IE - Irlanda 120
FI - Finlandia 96
IN - India 92
BD - Bangladesh 77
CA - Canada 65
JP - Giappone 51
TR - Turchia 46
KR - Corea 44
NL - Olanda 44
PL - Polonia 41
ID - Indonesia 40
PK - Pakistan 39
ES - Italia 37
AU - Australia 36
BE - Belgio 33
EG - Egitto 30
CH - Svizzera 28
TW - Taiwan 28
HU - Ungheria 18
IQ - Iraq 17
PH - Filippine 16
MX - Messico 15
ZA - Sudafrica 15
AR - Argentina 14
IR - Iran 14
RO - Romania 14
IL - Israele 12
AT - Austria 11
NG - Nigeria 11
GR - Grecia 10
PT - Portogallo 10
DK - Danimarca 9
EC - Ecuador 9
EE - Estonia 9
LT - Lituania 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
UZ - Uzbekistan 8
PE - Perù 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
MA - Marocco 6
MY - Malesia 6
HR - Croazia 5
JM - Giamaica 5
JO - Giordania 5
KG - Kirghizistan 5
BJ - Benin 4
CO - Colombia 4
CR - Costa Rica 4
ET - Etiopia 4
KW - Kuwait 4
NO - Norvegia 4
PR - Porto Rico 4
SA - Arabia Saudita 4
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
GP - Guadalupe 2
LB - Libano 2
NI - Nicaragua 2
PY - Paraguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CY - Cipro 1
GQ - Guinea Equatoriale 1
GT - Guatemala 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UG - Uganda 1
VE - Venezuela 1
Totale 15.747
Città #
Wilmington 3.078
Houston 2.797
Woodbridge 2.331
Fairfield 409
Ashburn 400
Singapore 358
Chandler 236
San Jose 216
Cambridge 168
Ann Arbor 167
Seattle 160
Hong Kong 118
Beijing 107
Rome 104
Dearborn 103
New York 102
Dublin 96
Jacksonville 88
Medford 86
Council Bluffs 75
Santa Clara 74
Helsinki 55
Los Angeles 55
The Dalles 55
Lawrence 38
Tokyo 37
Dallas 33
Denver 33
Moscow 31
Munich 31
Lauterbourg 30
Zhengzhou 30
Hanoi 29
Jönköping 28
Redwood City 28
Ho Chi Minh City 26
San Diego 26
Stockholm 25
Shanghai 24
Milan 23
Warsaw 21
Jakarta 19
Montreal 19
Boardman 18
Buffalo 18
London 18
Frankfurt am Main 17
Boston 16
São Paulo 15
Atlanta 14
Naples 14
Chicago 13
Duncan 13
Hefei 13
Menlo Park 13
Toronto 13
Norwalk 12
Redondo Beach 12
Lahore 11
Nanjing 11
North Bergen 11
Seoul 11
Brussels 10
Budapest 10
Central 10
Delhi 10
Hangzhou 10
Hyderabad 10
Salcedo 10
Taipei 10
Cairo 9
Johannesburg 9
Lagos 9
Lappeenranta 9
Ottawa 9
San Francisco 9
Sydney 9
Ankara 8
Bucharest 8
Da Nang 8
Haiphong 8
Kraków 8
Kunming 8
Madrid 8
New Delhi 8
Palo Alto 8
Phoenix 8
Baghdad 7
Bengaluru 7
Dong Ket 7
Florence 7
Lima 7
Nuremberg 7
Tallinn 7
Utrecht 7
Amsterdam 6
Brisbane 6
Chennai 6
Düsseldorf 6
Guayaquil 6
Totale 12.541
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.685
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 709
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 509
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 496
New topical treatments for psoriasis 469
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 467
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 448
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 445
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 437
Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept 435
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 427
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 426
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 420
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 413
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 410
Association between psoriasis and periodontitis, and efficacy of anti-TNF-α therapy: a case series 405
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 387
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 382
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy 379
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 378
Long-lasting remission of pemphigus vulgaris treated with rituximab 374
Histopathology of the skin in rheumatic diseases 374
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab 372
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 360
Treatment of Hailey-Hailey disease with topical calcitriol 354
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 345
Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-center, observational, retrospective, real-life study 339
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 319
A case of generalized pustular psoriasis and arthritis treated with ixekizumab 313
Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis 292
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections 292
The economic impact of biosimilars in Italy: a scenario analysis 259
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy 258
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 218
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series 195
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity 171
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis 153
Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting 134
Ixekizumab in nail psoriasis 131
Connective tissue nevus in Marfan syndrome successfully treated with intralesional steroid injections 124
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 113
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) 100
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 95
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice 86
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution 83
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis) 70
Totale 16.051
Categoria #
all - tutte 38.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022522 0 0 0 66 22 52 49 44 55 47 60 127
2022/2023760 62 74 37 92 61 111 65 63 91 22 38 44
2023/2024486 48 26 28 31 38 99 49 52 12 22 23 58
2024/20251.099 46 229 114 86 31 65 81 54 91 96 120 86
2025/20261.924 177 87 256 192 161 73 220 208 184 141 135 90
2026/2027639 98 88 308 145 0 0 0 0 0 0 0 0
Totale 16.051